Monopar (NASDAQ: MNPR) Stock Skyrockets on Upbeat MNPR-101 Radiopharmaceutical Program Findings
Monopar Therapeutics (NASDAQ: MNPR) stock soared after reporting promising preclinical results for the MNPR-101 radiopharmaceutical program. On Thursday, Monopar Therapeutics […]
